Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human FGF-8a Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Supplier:  R&D Systems™ 4745F8050

Catalog No. 4745F8050


Add to Cart
This item is not returnable. View return policy

Description

Description

The Recombinant Human FGF-8a Protein is derived from E. coli. The Recombinant Human FGF-8a Protein has been validated for the following applications: Bioactivity.
Specifications

Specifications

Lyophilized from a 0.2 μm filtered solution in MOPS, Na 2 SO 4 and EDTA.
21 kDa
50μg
12 months from date of receipt, ≤ -20° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, ≤ -20° C under sterile conditions after reconstitution.
Recombinant
2253
FGF-8 a Isoform
E. coli-derived human FGF-8 protein Gln23-Arg204,with an N-terminal Met
Unconjugated
95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Product Suggestions

Product Suggestions

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit